Related Experiment Video
Updated: Oct 17, 2025

Models of Bone Metastasis
Published on: September 4, 2012
What's new in the management of metastatic bone disease
Shinji Tsukamoto1, Costantino Errani2, Akira Kido3
1Department of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara-city, Nara, 634-8521, Japan. shinji104@mail.goo.ne.jp.
Abstract:
Metastatic bone disease is a common complication of malignant tumours. As cancer treatment improves the overall survival of patients, the number of patients with bone metastases is expected to increase. The treatments for bone metastases include surgery, radiotherapy, and bone-modifying agents, with patients with a short expected prognosis requiring less invasive treatment. Patients with metastatic bone disease show greatly varying primary tumour histology, metastases sites and numbers, and comorbidities. Therefore, randomised clinical trials are indispensable to compare treatments for these patients. This editorial reviews recent findings on the diagnosis and prognosis prediction and discusses the current treatment of patients with metastatic bone disease.
Related Concept Videos
Urinary Tract Calculi V: Nursing Management
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Urinary Tract Calculi III: Medical Management
Bone Remodeling
Osteoclasts in Bone Remodeling

